Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ansbert Gadicke

Affiliations

  • Large Shareholder, Director at Tcr2 Therapeutics Inc. (TCRR), 2019-02-21
  • Large Shareholder at Harpoon Therapeutics Inc. (HARP), 2019-02-14
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-11
  • Director at Radius Health Inc. (RDUS), 2017-02-22
  • Director at Chiasma Inc (CHMA), 2016-06-13
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-09
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Trivascular Technologies Inc. (TRIV), 2014-04-23
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2014-03-12
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Large Shareholder at Conatus Pharmaceuticals Inc (CNAT), 2013-08-01
  • Other at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-13
  • Large Shareholder at Kalobios Pharmaceuticals Inc (KBIO), 2013-02-07
  • Large Shareholder at Somaxon Pharmaceuticals Inc. (SOMX), 2012-07-10
  • Director at Verastem Inc. (VSTM), 2012-03-08
  • Large Shareholder at Zalicus Inc. (ZLCS), 2011-10-28
  • Other at Enteromedics Inc (ETRM), 2010-12-15
  • Large Shareholder at Pharmathene Inc (PIP), 2010-11-05
  • Large Shareholder at Aryx Therapeutics Inc. (ARYX), 2010-10-04
  • Large Shareholder at Senorx Inc (SENO), 2010-06-29
  • Other at Aveo Pharmaceuticals Inc (AVEO), 2010-03-18
  • Large Shareholder at Metabasis Therapeutics Inc (MBRX), 2010-01-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TCRR $15.00 1,373,333 Large Shareholder, Director 1,569,235 2019-02-19 Filing
HARP $14.00 500,000 Large Shareholder 8,422,847 2019-02-12 Filing
VSTM $10.00 3,740 Director 3,740 2012-02-01 Filing
VSTM $10.00 96,260 Director 2,029,593 2012-02-01 Filing
ETRM $1.15 1,765,499 Large Shareholder 5,790,841 2009-02-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
HARP $14.00 1,971 Large Shareholder 7,922,847 2019-02-12 Filing
PETX $20.16 26,713 Large Shareholder 0 2014-03-07 Filing